Paper9136753
Verapamil inhibition of enzymatic product efflux leads to improved detection of beta-galactosidase activity in lacZ-transfected cells.
Poot M and 1 other. Cytometry, 1997. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Verapamil inhibition of enzymatic product efflux leads to improved detection of beta-galactosidase activity in lacZ-transfected cells. Papers, record 9136753. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9136753
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Verapamil inhibition of enzymatic product efflux leads to improved detection of beta-galactosidase activity in lacZ-transfected cells.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluoresceins | Major topic |
| Galactosides | Major topic |
| Lac Operon | Major topic |
| Transfection | Major topic |
| Verapamil | Major topic |
| beta-Galactosidase | Major topic |
| 3T3 Cells | |
| Animals | |
| Cell Line | |
| Chloroquine | |
| Chromatography, High Pressure Liquid | |
| Fibroblasts | |
| Flow Cytometry | |
| Gene Expression | |
| Lysosomes | |
| Mice | |
| Substrate Specificity | |
| alpha-Galactosidase |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40603620 | Species-selective activation of a β-galactosidase fluorogenic probe. | Sci Rep | 2025 | https://conductscience.org/library/papers/40603620 | PubMed |
| 34904366 | Deletion of SA β-Gal+ cells using senolytics improves muscle regeneration in old mice. | Aging Cell | 2022 | https://conductscience.org/library/papers/34904366 | PubMed |
| 34439790 | Pancreatic Progenitor Commitment Is Marked by an Increase in Ink4a/Arf Expression. | Biomolecules | 2021 | https://conductscience.org/library/papers/34439790 | PubMed |
| 24390927 | Novel pancreas organogenesis markers refine the pancreatic differentiation roadmap of embryonic stem cells. | Stem Cell Rev Rep | 2014 | https://conductscience.org/library/papers/24390927 | PubMed |
| 22545119 | Construction of vascular tissues with macro-porous nano-fibrous scaffolds and smooth muscle cells enriched from differentiated embryonic stem cells. | PLoS One | 2012 | https://conductscience.org/library/papers/22545119 | PubMed |
| 9405676 | Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9405676 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLB1 | 2720 | PubTator's text mining | https://conductscience.org/library/genes/2720 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9136753
GET https://conductscience.org/api/papers/v1/9136753/authors